Risek Capsules

Risek Capsules – Comprehensive Acid-Related Disease Management

Risek is a established gastrointestinal treatment used for a wide variety of acid-related conditions in both adults and children. In adults, it is a primary choice for treating Gastro-Esophageal Reflux Disease (GERD), including the healing and long-term maintenance of erosive reflux esophagitis. Clinically, it is highly effective against both gastric and duodenal ulcers, and is utilized for the treatment and prophylaxis of ulcers associated with NSAID use. Risek also plays a critical role in the eradication of Helicobacter pylori when used in combination with appropriate antibiotics. For complex conditions, it manages pathological hypersecretory states like Zollinger-Ellison syndrome. Children over 1 year of age can use Risek for reflux esophagitis and symptomatic relief of heartburn. It also serves as a prophylaxis for acid aspiration during surgical procedures. As a proton pump inhibitor, it significantly reduces the amount of acid produced by the stomach, allowing the gastric and esophageal lining to recover from chronic irritation. Regular use provides stable and consistent protection, significantly improving the patient's digestive comfort and overall quality of life.

• Treats GERD, peptic ulcers, and Zollinger-Ellison syndrome.
• Used for H. pylori eradication and NSAID-associated ulcer prevention.
• Suitable for adults and children over 1 year of age.
• Available as: Capsules (20/40mg) and Injectable (40mg).